MFDS — authorised 26 August 2020
- Marketing authorisation holder: CASSIOPEA SPA
- Status: likely_approved
MFDS authorised Winlevi on 26 August 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 26 August 2020.
CASSIOPEA SPA holds the South Korean marketing authorisation.